Gyermekkori daganatok: vizsgálatok itt: Franciaország
206 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Strasbourg Cedex 2, Vandoeuvre Les Nancy
- Életkor
- 4 év to 21 év
- People
- 54
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT02897986 · EU 2024-517185-42-00 - 1/2. fázisTaking peopleAxitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
- Where
- Angers, Bordeaux, Lyon, Marseille, Paris, Strasbourg Cedex 2, Vandoeuvre Les Nancy
- Életkor
- 4 év to 25 év
- People
- 40
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06485908 · EU 2023-509585-38-00 - 1/2. fázisTaking peopleSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Where
- Marseille
- Életkor
- 1 év to 30 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07387926 - No phaseNot yet taking people in FranciaországEffect of the MIROKI Companion Robot on Anxiety in Pediatric Radiotherapy
- Where
- Montpellier
- Életkor
- 4 év and over
- People
- 6
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07645950 - 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Lyon, Nantes, Paris, Villejuif
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Le Kremlin-Bicêtre, Lyon, Marseille, Paris, Strasbourg, Villejuif
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Marseille, Paris, Poitiers, Strasbourg
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Paris, Pessac
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 2. fázisTaking peopleA Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
- Életkor
- 12 év to 17 év
- People
- 15 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07700758 · EU 2025-524515-37-00 - No phaseTaking peopleHealth and Exercise Response in Children With Chronic and Auto-immune Pathologies
- Where
- Clermont-Ferrand
- Életkor
- 6 év to 18 év
- People
- 300
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT03913962 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Bordeaux, Caen Cedex 9, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes Cedex 1, Nice, Paris, Poitiers, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - No phaseNot yet taking people in FranciaországPrognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Rennes, Rouen, Saint-Denis, Saint-Etienne, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- Up to 25 év
- People
- 150
- Run by
- Institut Curie
See details and how to joinNCT07924384 - 2. fázisNot yet taking people in FranciaországAnalysis of histological risk factors and biomarkers in paediatric retinoblastoma
- Where
- Amiens Cedex 1, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Rennes, Saint-Etienne, St Denis, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
- Életkor
- Up to 17 év
- People
- 50
- Run by
- Institut Curie
See details and how to join2024-515962-15-00 - 1. fázisTaking peopleA Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Marseille, Pierre-Bénite, Toulouse, Tours
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Lyon, Saint-Herblain, Toulouse Cedex 9, Villejuif
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - No phaseTaking peopleAn Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
- Where
- Villejuif
- Életkor
- 2 év and over
- People
- 160
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05481502 - 3. fázisTaking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Nantes, Nîmes, Paris, Saint-Herblain, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - 1/2. fázisTaking peopleA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Bordeaux, Villejuif
- Életkor
- 6 hónap to 30 év
- People
- 65 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05533775 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Bordeaux, Villejuif
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Besançon, Marseille, Nantes, Paris, Pierre-Bénite, Strasbourg, Strasbourg Cedex 2, Toulouse, Tours, Vandoeuvre Les Nancy, Villejuif
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - No phaseTaking peopleIrradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
- Where
- Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris, Rennes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 6 év to 14 év
- People
- 130
- Run by
- Institut Claudius Regaud
See details and how to joinNCT06599879 - 2/3. fázisTaking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Creteil Cedex, Dijon, Lille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Rennes Cedex 9, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
- People
- 1541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Villejuif
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1/2. fázisTaking peopleA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
- Életkor
- 1 hónap to 17 év
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891